Pyruvic-1-13C 是同位素标记的丙酮酸前体。 应用 超极化13C标记的丙酮酸及其代谢产物乳酸,用于对实体肿瘤实时代谢通量进行成像,评估肿瘤对化疗、放疗和靶向mTOR药物的反应情况。 Pyruvic-1-13C is isotopic labeled precursor of pyruvic acid.Hyperpolarized13C-labeled pyruvate and its metabolite lactate has been used to image real time metabolic flux in solid tumors and assess tumor response to chemotherapy, radiation, and agents targeting mTOR.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Pyruvic acid (1-¹³C)
Dangerous GoodsCAS number:99124-30-8 molecular formula:CH3CO13CO2H
overview
compound introduction
Specs
| Chinese alias | 丙酮酸-1-13C | 丙酮酸-1-13C(游离酸) | α-酮丙酸-1-13C | 2-氧丙酸-1-13C | 13C 标记丙酮酸 | 丙酮酸-1-13C | ||
| English alias | PYRUVIC ACID 1-C-13, HYPERPOLARIZED | HY-Y0781S1 | 13C1-Pyruvic acid | UNII-2GIJ84D9UB | HYPERPOLARIZED 1-13C-PYRUVIC ACID | Pyruvic-1-13C acid (free acid), >=99 atom % 13C, >=99% (CP) | Q27254717 | DTXSID60436366 | Pyruvic-1-13C acid | Pyruvic-1-13C acid | ||
| CAS number | 99124-30-8 | molecular formula | CH3CO13CO2H |
| molecular weight | 89.05 g/mol | Exact mass | ≥99 atom% 13C,≥99% |
| PSA | 54.400 Ų | logp | -0.3 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
pictogram:
GHS05
Signal word:
Danger
Hazard Statement:
H314: 造成严重的皮肤灼伤和眼睛损伤 H318: 造成严重的眼睛损伤
Statement of Preventive Measures:
P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P321: 特殊处理(请参阅此标签上的...)。 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P264: 处理后要彻底洗手。 P260: 不要吸入灰尘/烟雾/气体/雾/蒸汽/喷雾。 P301+P330+P331: 如误吞咽:漱口。不要诱导呕吐。 P304+P340: 如误吸入:将人转移到空气新鲜处,保持呼吸舒适体位。 P363: 再次使用之前,请清洗受污染的衣物。 P264+P265: 处理后彻底洗手[和…]。不要触摸眼睛。 P
UN Number:
3265
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 1 shareMSDS
99124-30-8 | Pyruvic-1-13C acid (free acid).pdf





